Valbenazine(NBI-98854)|VMAT2 inhibitor

Valbenazine(NBI-98854)|VMAT2 inhibitor


Valbenazine(NBI-98854) is a potent and selective VMAT2 inhibitor..

Product Name: Valbenazine（NBI-98854）|Cat No. DC9816|CAS: 1025504-45-3|Other names:NBI-98854; NBI 98854; NBI98854; Valbenazine|MW: 418.28|Molecule Formular: C24H38N2O4 |Purity>98%

Valbenazine, aslo known as NBI-98854, is a potent and selective VMAT2 inhibitor. NBI-98854 is effective in regulating the levels of dopamine release during nerve communication, while at the same time having minimal impact on the other monoamines. NBI-98854 is promising agent for the treatment of tardive dyskinesia.NBI-98854 significantly improved tardive dyskinesia and was well tolerated in patients. These results support the phase 3 clinical trials of NBI-98854 now underway.